Member Info for Matador78

Well won't you have a look at what one of our boys just found...

Despite the drug still being illegal in Britain, the farm has a government licence issued by the Home Office to produce and export cannabis to countries such as Canada where the drug is permitted. Only 12 such licences have been awarded.

Bridge Farm, a horticulture company based in Lincolnshire, has been acquired by Artemis Growth Partners for about $81m (£66m). The fund’s partners, many of whom are former Goldman Sachs and JPMorgan executives, has a large portfolio of companies that sell and advocate the use of cannabis for a number of different purposes including for medicinal use.

https://www.theguardian.com/society/2020/may/15/uk-cannabis-firm-bought-by-us-based-fund-in-multi-million-pound-deal

Stephen Parker should take a note of how Lew Bender does business.

And either learn to emulate him or find someone who can fill those shoes.

http://www.pharmexec.com/episode-56-killing-cancer-through-direct-injection

I'm not here to convince you otherwise.

I find information and I post it. As long as it isn't false or misleading I'm happy.

You guys make your own decisions. : )

Listen to me..

New Today

http://www.pharmexec.com/episode-56-killing-cancer-through-direct-injection

https://www.sbcnews.co.uk/features/2020/05/14/stian-hornsletten-everymatrix-closing-gap-sports-casino/

We’ve seen massive three-digits growth week-over-week in our reporting, so there is solid potential for virtual sports in the long run. Some key advantages of virtuals include eliminating long waiting times associated with real-life sports events, quick access to a wide variety of content, and having an innate attractiveness for computer games enthusiasts.

Virtuals sports are a gaming category with its own complex environment, and we are providing operators with quite a lot of content choices. To date, we made available content from Global Bet, Kiron, NSoft, Golden Race, Leap Gaming, 1×2 Gaming, Betradar, and we are already looking to integrate another five to six additional providers.

https://www.igamingbusiness.com/1x2-network-and-leap-gaming-extend-partnership

https://dailyscience.me/2020/05/13/longevity-biotech-market-2020-industry-research-report-segment-by-top-players-regional-analysis-product-types-marketing-channel-and-forecast-2015-2027/

May 13, 2020 | No Comments


The report titled Global Longevity Biotech market report 2020 abridges some imperative components of the business. Longevity Biotech industry current circumstances, market requests and pivotal business techniques that are picked by the industry players and Longevity Biotech development situation. The business strategies opted by players are analyzed in the Longevity Biotech report based on leading players, product type, application and worldwide regions.

As compared to the current market scenario, the global Longevity Biotech industry report discloses various facts related to driving factors, trends, opportunities, restrictions, and major Longevity Biotech challenges encountered by the market players. The global Longevity Biotech market report has taken into consideration all the major as well as minor aspects related to the development of the Longevity Biotech market. Through various market stats, methodologies, Longevity Biotech in-depth case studies, market revenue, gross margin, consumption, cost structure, market capacity, export, import, market shares, production process, and many Longevity Biotech marketing networks etc.

https://www.prnewswire.com/news-releases/portage-is-pleased-to-announce-the-appointment-of-allan-l-shaw-as-cfo-301057306.html

TORONTO, May 12, 2020 /PRNewswire/ - Portage Biotech Inc. (PBT.U: CSE, PTGEF: OTC Markets) ("Portage" or the "Company") a leader in the early stage immune oncology space announced today the appointment of Allan L. Shaw to Chief Financial Officer at the Portage level and will assist in its portfolio companies as well.

Allan brings more than two decades of public company financial, operational, and strategic global business leadership. Mr. Shaw is a four-time public company Chief Financial Officer with proven skills across multiple finance disciplines: corporate finance, capital markets and strategic transactions as well as a broad base of expertise in corporate governance and risk management. He structured, directed, negotiated and closed over $4 billion in public and private financings for several companies. Mr. Shaw has served on five public boards including chairing two audit committees/two compensation committees and is currently involved with a portfolio of healthcare activities. Most recently, Mr. Shaw was the Chief Financial Officer and Treasurer of Syndax Pharmaceuticals, Inc. and was Managing Director of Alvarez & Marsal LLC, a global professional services firm, and led their biopharmaceutical consulting practice.

https://casino.buzz/2020/05/12/microgaming-strengthens-its-aggregated-content-offering-this-may/

Microgaming has been at the forefront of the gaming industry for over 25 years, providing its customers with a wealth of quality and innovative content to increase player engagement. The leading supplier and aggregator of online casino software works with a growing network of content partners, having welcomed the likes of LiveG24, Betgames.TV, Tom Horn Gaming and Inspired within the last few weeks alone. These successful collaborations ensure operator access to a premium offering of diverse games, including live dealer content such as the innovative Real Roulette created by Real Dealer Studios, and a host of high-end virtual and instant sports from a wealth of providers, including Leap Gaming, 1X2 Gaming and Kiron Interactive.

https://europeangaming.eu/portal/latest-news/2020/05/07/70097/groovegaming-keep-it-simple-with-new-simpleplay-foray/

I don't think its lazy YNWA91. We had a good few positive interviews Pre Pandemic talking about IPO's and potential dividends this year.

Oils turned negative, otherwise rubbish pharma stocks that no one is interested in have rocketed on a sniff of any covid related hype. So naturally the unwashed have bought straight into it and having seen that a lot of the usual hawks who frequent the boards here have taken full advantage and sold here and piled their money elsewhere to create false interest.

The pharmas will spike or hold a placing and the boys club who have gone quiet on this board will return in about 4 weeks time on full ramp.

Thats not to say FFWD is a poor choice it just is what it is.

I can wait.

I wouldn't want to burden anyone with carrying round stock that they weren't happy with.

I'll hold it for you. I'll give it back when their arms aren't so tired

Promise.

Thats only natural why risk your money here at 2 bit FFWD when you could risk it elsewhere?

Probably a good idea to sell everything and buy PREM or a company that sells Mattresses. I would give you my full backing.

It's not moving much because we're in the middle of a Pandemic. Nothing is moving much.

If FFWD released good news now people would sell into liquidity.

I'm happy enough as it is. Things are ticking over

EMMAC is building
YOOMA are doing their social Commerce thing (Research Wechat) and look at the possibilities.
Leap is growing month on Month
Portage have just upped their stake in Suagatuck

Every time someone hit's the sell button myself and a few others are chipping away ensuring there's less for them to buy back into.

It's a funny old game.

60p

http://www.chinainfluencermarketing.com/2020/01/cmp58-is-ecommerce-livestreaming-in-china-a-good-fit-for-your-brand/

Listen to me.

https://ronwardle.com/?fbclid=IwAR17HmjA4KunGbBQmfmge6CIuT3e6auizi5wXEW-KFET4n77HzmOqle-0Zk

Longevity Vision Fund, the venture firm funding solutions focused on longetivity and extending life spans, has raised $62M in a fund close according to a recent SEC filing. The filing does not indicate a total offering amount but does indicate that this close came from three limited partners. Founded by Sergey Young (Peak State Ventures, BOLD Capital Partners) in 2018, Longetivity Vision Fund has made investments in companies like Exom, Freenome, Insilico Medicine, Juvenescence, and Sigilon.

The top create a strategy

The Bottom work believing there is a strategy

The middle walk around shrugging their shoulder wondering what a strategy is.

If you guys only knew..

("Tekcapital" or the "Company")



Conditional Placing to raise £925,000

Notice of General Meeting



Tekcapital plc, (AIM: TEK) the UK intellectual property investment group focused on creating marketplace value from investing in university technology, announces that it has conditionally raised a total of £925,000 (US$1.15 million) (before expenses) by way of the issue of, in aggregate, 9,250,000 new ordinary shares of 0.4 pence each in the Company (the "New Ordinary Shares"), at 10 pence per share (the "Placing Price") (together, the "Placing").

Key Highlights:

- £925,000 (US$1.15 million) (before expenses) raised by means of a conditional fundraise through the issue of, in aggregate 9,250,000 Placing Shares at 10 pence per share.

- Funds raised will primarily be committed to Tekcapital's portfolio of companies and to provide additional working capital for the Company.

- The Placing Price represents a discount of approximately 13 per cent. to the closing mid-market price of 11.5 pence on 30 April 2020, being the last trading day prior to the release of this announcement of the Placing.

- The Placing Shares will represent approximately 11.78 per cent. of the Existing Ordinary Shares and will, when issued, represent approximately 10.54 per cent. of the Enlarged Share Capital.

- The Placing, details of which are set out below, was undertaken by the Company's broker SP Angel Corporate Finance LLP.

- The Placing will be subject to Tekcapital's shareholders' approval at a general meeting (the "General Meeting") to be at 10.00a.m. on 19 May 2020.

- A Circular which sets out details of the conditional Placing and also includes a Notice of General Meeting will be sent to shareholders later today (the "Circular").

- Certain Directors who hold Existing Ordinary Shares have irrevocably undertaken to vote in favour of the Resolutions, in respect of their shares, representing 11 per cent of the Existing Ordinary Shares.

Clifford M. Gross Ph.D., Executive Chairman of Tekcapital plc commented:

"We are pleased to announce the completion of this placing as it will enable us to accelerate the further development of our portfolio companies."

Jim Mellon holds 20,500,000 (20,500,000) shares in EMMAC Life Sciences Limited ("EMMAC"), which equates to 7.1% of the shares in issue.